Changes of gait pattern in children with Charcot-Marie-Tooth disease type 1A: A 18 months follow-up study

Journal of NeuroEngineering and Rehabilitation

Volumn 10, Issue 1, 2013, Pages

  Ferrarin, Maurizio ^a   Lencioni, Tiziana ^a   Rabuffetti, Marco ^a   Moroni, Isabella ^b   Pagliano, Emanuela ^b   Pareyson, Davide ^b  

^a IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Charcot Marie Tooth disease; Children; Follow up; Foot drop; Gait analysis; Heel walking; Push off; Toe walking

Indexed keywords

CHILD; COMPLICATION; DISEASE COURSE; FEMALE; FOLLOW UP; GAIT; GAIT DISORDERS, NEUROLOGIC; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MALE; ARTICLE; NEUROLOGIC GAIT DISORDER;

CHARCOT-MARIE-TOOTH DISEASE; CHILD; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GAIT; GAIT DISORDERS, NEUROLOGIC; HUMANS; MALE;

EID: 84879812609     PISSN: None     EISSN: 17430003     Source Type: Journal    
DOI: 10.1186/1743-0003-10-65     Document Type: Article

References (25)

1. Diagnosis, natural history, and management of Charcot-Marie-Tooth disease. Pareyson D, Marchesi C, Lancet Neurol 2009 8 7 654 667 10.1016/S1474-4422(09)70110-3 19539237
2. Natural history of CMT1A including QoL: a 2-year prospective study. Padua L, Pareyson D, Aprile I, Cavallaro T, Quattrone A, Rizzuto N, Vita G, Tonali P, Schenone A, Neuromuscul Disord 2008 8 3 199 203
3. 168th ENMC International Workshop: outcome measures and clinical trials in Charcot-Marie-Tooth disease (CMT). Reilly MM, Shy ME, Muntoni F, Pareyson D, Neuromuscul Disord 2010 20 12 839 846 10.1016/j.nmd.2010.08.001 20850975
4. Reliability and validity of the CMT neuropathy score as a measure of disability. Shy ME, Blake J, Krajewski K, Fuerst DR, Laura M, Hahn AF, Li J, Lewis RA, Reilly M, Neurology 2005 64 7 1209 1214 10.1212/01.WNL.0000156517. 00615.A3 15824348
5. Reliability of clinical outcome measures in Charcot-Marie-Tooth disease. Solari A, Laurà M, Salsano E, Radice D, Pareyson D, CMT-TRIAAL Study Group, Neuromuscul Disord 2008 18 1 19 26 10.1016/j.nmd.2007.09.006 17964785
6. Outcome measures for Charcot-Marie-Tooth disease: clinical and neurofunctional assessment in children. Pagliano E, Moroni I, Baranello G, Magro A, Marchi A, Bulgheroni S, Ferrarin M, Pareyson D, J Peripher Nerv Syst 2011 16 3 237 242 10.1111/j.1529-8027.2011.00357.x 22003938
7. Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disability. Burns J, Ouvrier R, Estilow T, Shy R, Laurá M, Pallant JF, Lek M, Muntoni F, Reilly MM, Pareyson D, Acsadi G, Shy ME, Finkel RS, Ann Neurol 2012 71 5 642 652 10.1002/ana.23572 22522479
8. Foot drop and plantar flexion failure determine different gait strategies in Charcot-Marie-Tooth patients. Don R, Serrao M, Vinci P, Ranavolo A, Cacchio A, Ioppolo F, Paoloni M, Procaccianti R, Frascarelli F, De Santis F, Pierelli F, Frascarelli M, Santilli V, Clin Biomech (Bristol, Avon) 2007 22 905 916 10.1016/j.clinbiomech.2007.06.002
9. The characteristics of gait in Charcot-Marie-Tooth disease types I and II. Newman CJ, Walsh M, O'Sullivan R, Jenkinson A, Bennett D, Lynch B, O'Brien T, Gait Posture 2007 26 120 127 10.1016/j.gaitpost.2006.08.006 17010610
10. Gait pattern classification in children with Charcot-Marie-Tooth disease type 1A. Ferrarin M, Bovi G, Rabuffetti M, Mazzoleni P, Montesano A, Pagliano E, Marchi A, Magro A, Marchesi C, Pareyson D, Moroni I, Gait Posture 2012 35 1 131 137 10.1016/j.gaitpost.2011.08.023 21944474
11. Gait analysis in a patient with severe Charcot-Marie-Tooth disease: a case study with a new orthotic device for footdrop. Vinci P, Paoloni M, Ioppolo F, Gargiulo P, Santilli V, Eur J Phys Rehabil Med 2010 46 3 355 361 20927001
12. Neuropathy progression in Charcot-Marie-Tooth disease type 1A. Shy ME, Chen L, Swan ER, Taube R, Krajewski KM, Herrmann D, Lewis RA, McDermott MP, Neurology 2008 70 5 378 383 10.1212/01.wnl.0000297553.36441.ce 18227419
13. The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study. Verhamme C, van Schaik IN, Koelman JH, de Haan RJ, de Visser M, Brain 2009 132 Pt 12 3252 3262 19843647
14. Sagittal joint kinematics, moments, and powers are predominantly characterized by speed of progression, not age, in normal children. Stansfield BW, Hillman SJ, Hazlewood ME, Lawson AA, Mann AM, Loudon IR, Robb JE, J Pediatr Orthop 2001 21 3 403 411 11371829
15. Muscle activation pattern and gait biomechanics after total knee replacement. Benedetti MG, Catani F, Bilotta TW, Marcacci M, Mariani E, Giannini S, Clin Biomech (Bristol, Avon) 2003 18 9 871 876 10.1016/S0268-0033(03)00146-3
16. Natural progression of gait in children with cerebral palsy. Bell KJ, Ounpuu S, DeLuca PA, Romness MJ, J Pediatr Orthop 2002 22 5 677 682 12198474
17. A modular protocol for the analysis of movement in children. Rabuffetti M, Crenna P, Gait Posture 2004 20 77 S78
18. Symmetry of foot alignment and ankle flexibility in paediatric Charcot-Marie-Tooth disease. Burns J, Ouvrier R, Estilow T, Shy R, Laurá M, Eichinger K, Muntoni F, Reilly MM, Pareyson D, Acsadi G, Shy ME, Finkel RS, Clin Biomech (Bristol, Avon) 2012 Epub ahead of print
19. Changes in the gait patterns of growing children. Beck RJ, Andriacchi TP, Kuo KN, Fermier RW, Galante JO, J Bone Joint Surg Am 1981 63 9 1452 1457 7320036
20. Scaling gait data to body size. Hof AL, Gait Posture 1996 4 3 222 223 10.1016/0966-6362(95)01057-2
21. Winter DA, The biomechanics and motor control of human gait: normal, elderly, and pathological Waterloo, Ontario: University of Waterloo Press 2 1991
22. Reliability of instrumented movement analysis as outcome measure in Charcot-Marie-Tooth disease: results from a multitask locomotor protocol. Ferrarin M, Bovi G, Rabuffetti M, Mazzoleni P, Montesano A, Moroni I, Pagliano E, Marchi A, Marchesi C, Beghi E, Pareyson D, Gait Posture 2011 34 1 36 43 10.1016/j.gaitpost.2011.03.007 21511477
23. Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial. Micallef J, Attarian S, Dubourg O, Gonnaud PM, Hogrel JY, Stojkovic T, Bernard R, Jouve E, Pitel S, Vacherot F, Remec JF, Jomir L, Azabou E, Al-Moussawi M, Lefebvre MN, Attolini L, Yaici S, Tanesse D, Fontes M, Pouget J, Blin O, Lancet Neurol 2009 8 12 1103 1110 10.1016/S1474-4422(09)70260-1 19818690
24. Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. Pareyson D, Reilly MM, Schenone A, Fabrizi GM, Cavallaro T, Santoro L, Vita G, Quattrone A, Padua L, Gemignani F, Visioli F, Laurà M, Radice D, Calabrese D, Hughes RA, Solari A, CMT-TRIAAL; CMT-TRAUK groups, Lancet Neurol 2011 10 4 320 328 10.1016/S1474-4422(11)70025-4 21393063
25. A modified peripheral neuropathy scale: the overall neuropathy limitations scale. Graham RC, Hughes RA, J Neurol Neurosurg Psychiatry 2006 77 8 973 976 10.1136/jnnp.2005.081547 16574730